These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 14508696)

  • 1. [Gastrointestinal stromal tumors].
    Schlemmer M; Milani V; Tschoep K; Fahn W; Wendtner CM
    Dtsch Med Wochenschr; 2003 Sep; 128(39):2015-9. PubMed ID: 14508696
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gastrointestinal stromal tumor].
    Nishida T; Ohmori T; Matsuda H
    Gan To Kagaku Ryoho; 2004 Mar; 31(3):331-6. PubMed ID: 15045935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gastrointestinal stromal tumors: open problems].
    Peparini N; Maturo A
    G Chir; 2002 Oct; 23(10):357-9. PubMed ID: 12611255
    [No Abstract]   [Full Text] [Related]  

  • 4. Gastrointestinal stromal tumour--a paradigm shift in management of solid tumours.
    Bapsy PP; Prabhash K; Babu KG; Girish MH
    J Assoc Physicians India; 2003 Aug; 51():801-4. PubMed ID: 14651144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gastrointestinal stromal tumors: a new model for target therapy].
    Tonini G; Vincenzi B; La Cesa A
    Clin Ter; 2003; 154(2):75-6. PubMed ID: 12856363
    [No Abstract]   [Full Text] [Related]  

  • 6. [GIST--a significantly more common tumor than earlier apprehended. New discoveries on the pathogenesis of GIST yielded new medical treatment].
    Nilsson B; Andersson J; Meis-Kindblom J; Kindblom LG; Engström K; Stierner U; Bümming P; Ahlman H
    Lakartidningen; 2003 Mar; 100(11):930-4, 936-8. PubMed ID: 15148719
    [No Abstract]   [Full Text] [Related]  

  • 7. Current management of GIST.
    Blanke C
    Clin Adv Hematol Oncol; 2004 May; 2(5):280, 283. PubMed ID: 17682286
    [No Abstract]   [Full Text] [Related]  

  • 8. [Gastrointestinal stromal tumors (GIST)].
    Reichardt P; Pink D; Mrozek A; Lindner T; Hohenberger P
    Z Gastroenterol; 2004 Apr; 42(4):327-31. PubMed ID: 15095124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [At last, an effective therapy for non-differentiated GI sarcomas (gastro intestinal stromal tumor)].
    Des Guetz G; De Mestier P; Pierga JY
    J Chir (Paris); 2002 Oct; 139(5):268-73. PubMed ID: 12410126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late resistance to imatinib therapy in a metastatic gastrointestinal stromal tumour is associated with a second KIT mutation.
    Wakai T; Kanda T; Hirota S; Ohashi A; Shirai Y; Hatakeyama K
    Br J Cancer; 2004 Jun; 90(11):2059-61. PubMed ID: 15150562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tyrosine kinase inhibitor as a targeted therapy for GIST tumors].
    Joensuu H
    Duodecim; 2002; 118(22):2305-12. PubMed ID: 12523107
    [No Abstract]   [Full Text] [Related]  

  • 12. [New oncological treatment principle with imatinib].
    Kuenen BC; Pinedo HM
    Ned Tijdschr Geneeskd; 2003 Oct; 147(42):2044-5. PubMed ID: 14606348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Imatinib, a specific tyrosine-kinase inhibitor, for the treatment of patients with a gastrointestinal stroma cell tumor].
    Gelderblom H; Hogendoorn PC; van der Graaf WT; Verweij J
    Ned Tijdschr Geneeskd; 2003 Oct; 147(42):2051-5. PubMed ID: 14606351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gastrointestinal stromal tumors. Current data].
    Arfaoui D; Yacoubi MT; Elloumi H; Frikha F; Mokni M; Ajmi S
    Tunis Med; 2003 Dec; 81(12):907-13. PubMed ID: 14986524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of c-kit/SCF in cause and treatment of gastrointestinal stromal tumors (GIST).
    Ali S; Ali S
    Gene; 2007 Oct; 401(1-2):38-45. PubMed ID: 17659849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors.
    Chen LL; Trent JC; Wu EF; Fuller GN; Ramdas L; Zhang W; Raymond AK; Prieto VG; Oyedeji CO; Hunt KK; Pollock RE; Feig BW; Hayes KJ; Choi H; Macapinlac HA; Hittelman W; Velasco MA; Patel S; Burgess MA; Benjamin RS; Frazier ML
    Cancer Res; 2004 Sep; 64(17):5913-9. PubMed ID: 15342366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New activating mutation in GI stromal tumors.
    Lang L
    Gastroenterology; 2003 Mar; 124(3):596. PubMed ID: 12612892
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathological response of gastrointestinal stromal tumour to imatinib treatment correlates with tumour KIT mutational status in individual tumour clones.
    Loughrey MB; Beshay V; Dobrovic A; Zalcberg J; Waring PM
    Histopathology; 2006 Jul; 49(1):99-100. PubMed ID: 16842259
    [No Abstract]   [Full Text] [Related]  

  • 19. Gastrointestinal stromal tumors: a paradigm for molecularly targeted therapy.
    von Mehren M
    Cancer Invest; 2003; 21(4):553-63. PubMed ID: 14533446
    [No Abstract]   [Full Text] [Related]  

  • 20. [Small-molecule inhibitors against KIT and PDGFRs especially in GISTs].
    Shiba K; Matsumoto T; Hirota S
    Gan To Kagaku Ryoho; 2009 Jul; 36(7):1080-5. PubMed ID: 19620796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.